REPORT

Prioritizing efficiency while outsourcing

Larger companies outsourced the large majority of their validation activities, something smaller companies were unable or unwilling to do. Both agree that efficiency was the key goal for the year.

KEY 2023 TAKEAWAYS:

  • Most validation teams are fewer than six people

  • Large companies outsource over 75% of their work, smaller companies less than half

  • Data integrity was the #1 concern of validation teams

  • Human resource shortages a constraint on validation

Validation Industry Insight

About the 2023 Author

Jonathan Kay

Jonathan Kay is a trusted advisor to life sciences and digital health companies. He has supported the successful development, launch, and commercialization of dozens of medical devices, diagnostics, vaccines, and therapeutics to address unmet needs in cancer, cardiovascular disease, infectious disease, rare disease, and more. His mission is to advance new technologies that save and improve lives and expand access, equity, and value. He does that by helping industry to understand complex landscapes through market research. In 1999, Jonathan co-founded one of the first online medical market research firms, helping to digitally transform that industry. He has served in leadership roles in the US and globally in WPP agencies, including PSB Research, where he formed the healthcare practice and led it for a decade, TNS Healthcare, and Kantar Health (now Cerner Enviza / Oracle).

Jonathan earned a B.A. from Cornell and a Master in Public Policy from the Harvard Kennedy School of Government. He is fascinated by the application of artificial intelligence to healthcare and completed studies of ‘Artificial Intelligence: Implications for Business Strategy’ at MIT. Jonathan is also a board member of the Brem Foundation to Defeat Breast Cancer and a volunteer mentor to CEOs of start-ups at the Maryland Tech Council.